ArkeaBio
4 known investors
Find your way into ArkeaBio
410 people in our graph share verified history with the ArkeaBio team — schools, employers, funds. One of them is your warm intro.
ArkeaBio develops a methane-reducing vaccine for cattle that lowers agricultural emissions without disrupting farm operations, targeting livestock producers to enable low-carbon dairy and beef production. The vaccine activates a natural immune response in ruminants and integrates seamlessly with existing farming practices.
Founders & leadership


Investors · 4
How we know: arkeabio.com · Not right? Tell us
How we know: NYA Ventures's portfolio page · Not right? Tell us
How we know: Rabo Corporate Venturing's portfolio page · Not right? Tell us
How we know: agfundernews.com · Not right? Tell us
Funding
SEC filings, press & company announcements$26.5M disclosed across 1 of 4 rounds · 2022–2025
- Undisclosed amountSeries A1Sep 2025
AgriZeroNZ (lead), Breakthrough Energy Ventures (lead)
Source ↗ - Undisclosed amountSeries A+Sep 2025
AgriZeroNZ (lead), Breakthrough Energy Ventures (lead)
Source ↗ - $26.5MSeries AMay 2024 · 2 sourcesSource ↗
- Undisclosed amountSeedDec 2022Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does ArkeaBio do?
- ArkeaBio develops a methane-reducing vaccine for cattle that lowers agricultural emissions without disrupting farm operations, targeting livestock producers to enable low-carbon dairy and beef production. The vaccine activates a natural immune response in ruminants and integrates seamlessly with existing farming practices.
- Who are ArkeaBio's investors?
- ArkeaBio's investors include Breakthrough Energy Ventures, NYA Ventures, Rabo Corporate Venturing, AgriZeroNZ.
- How much funding has ArkeaBio raised?
- ArkeaBio has disclosed $26.5M raised across 1 of its 4 known rounds.



